Compartir
Cannabinoids and Neuropsychiatric Disorders (en Inglés)
Murillo-Rodriguez, Eric ; Pandi-Perumal, S. R. ; Monti, Jaime M. (Autor)
·
Springer
· Tapa Dura
Cannabinoids and Neuropsychiatric Disorders (en Inglés) - Murillo-Rodriguez, Eric ; Pandi-Perumal, S. R. ; Monti, Jaime M.
$ 205.799
$ 342.998
Ahorras: $ 137.199
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Lunes 29 de Julio y el
Miércoles 07 de Agosto.
Lo recibirás en cualquier lugar de Argentina entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Cannabinoids and Neuropsychiatric Disorders (en Inglés)"
This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues.Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.